Pfizer to buy cancer dug maker Array BioPharma for $10.64 billion
June 17, 2019 at 09:49 AM EDT
Pfizer Inc. agreed to buy Array BioPharma Inc. for $10.64 billion in cash, as the pharmaceutical company looks to expand its pipeline of cancer therapies.
